Robuta

https://www.biospace.com/dermtech-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-august-25-2023 DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 25, 2023 -... Aug 28, 2023 - DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics technology, announced the grant to six new employees of restricted... https://www.businesswire.com/news/home/20240603658472/en/Longboard-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurolog... https://www.biospace.com/karyopharm-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-december-01-2023 Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December... Dec 4, 2023 - Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Company granted an aggregate of... https://www.biospace.com/vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-february-02-2024 Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 02, 2024 - BioSpace Oct 10, 2024 - Vor Bio announced that, effective as of January 29, 2024, the Compensation Committee of the Board of Directors granted stock options to purchase an aggregate... https://www.biospace.com/press-releases/zentalis-pharmaceuticals-announces-inducement-grant-under-nasdaq-listing-rule-5635c4-may-1-2025 Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 1,... https://finviz.com/news/344274/ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.biospace.com/press-releases/neuronetics-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-june-19-2025 Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 19, 2025 - BioSpace https://www.businesswire.com/news/home/20250808407224/en/Neurogene-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurologic... announcesinducementgrants https://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/5635.0.40.001Nov%202003?OpenDocument 5635.0.40.001 - Cash Management Trusts, Australia: Data Report, Nov 2003 0 40cash management https://www.biospace.com/press-releases/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-february-5-2025 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - February 5,... https://www.biospace.com/curis-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-april-06-2023 Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - April 06, 2023 - BioSpace Apr 6, 2023 - Curis, Inc. announced that on March 31, 2023, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock... https://www.biospace.com/sarepta-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-march-29-2024 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 29,... Apr 1, 2024 - Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, granted equity awards on March 29, 2024 that were previously approved... https://www.biospace.com/ptc-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-may-15-2020 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 15, 2020 -... May 18, 2020 - PTC Therapeutics, Inc. announced that on May 11, 2020 it approved non-statutory stock options to purchase an aggregate of 50,025 shares of its common stock and... https://www.businesswire.com/news/home/20260410491659/en/Quantum-Si-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.seoclerk.com/login?r=b3JkZXIvNTYzNQ== Login and redirect to https://www.seoclerk.com/order/5635 - SEOClerks The largest SEO Marketplace on the planet. redirecthttps https://menafn.com/1111060298/Candel-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). NEEDHAM, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics,... https://stockhouse.com/news/press-releases/2026/03/17/imagenebio-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 2026-03-17 | ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NDAQ:IMA |... (2026-03-17 | NDAQ:IMA) ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.compuserve.com/pf/story/0022/20260415/9688703.htm Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://www.biospace.com/sarepta-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-september-29-2023 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September... Oct 2, 2023 - Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, granted equity awards on September 29, 2023 that were previously... https://www.biospace.com/blueprint-medicines-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-april-04-2024 Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 04,... Apr 5, 2024 - Blueprint Medicines Corporation, announced that, effective April 1, 2024, the Compensation Committee of Blueprint Medicines' Board of Directors granted... https://www.biospace.com/press-releases/atyr-pharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-two-employees-nonstatutory-stock-options aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) two employees... https://menafn.com/1111060302/Xenon-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). VANCOUVER, British Columbia and BOSTON, MA, May 01, 2026 (GLOBE NEWSWIRE)... https://finviz.com/news/293110/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.biospace.com/mirati-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-may-5-2023 Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - May 5, 2023 -... May 6, 2023 - Mirati Therapeutics, Inc. today announced that the company granted equity awards to 2 new employees with a grant date of May 1, 2023, as equity inducement... https://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/5635.0.40.001Main+Features1Apr%202001?OpenDocument 5635.0.40.001 - Cash Management Trusts, Australia: Data Report, Apr 2001 0 40cash management https://www.oracle.com/asean/corporate/accessibility/templates/t2-5635.html VPAT - t2-5635 vpatt25635 https://www.biospace.com/olema-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-december-04-2023 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 04, 2023 -... Dec 5, 2023 - Olema Pharmaceuticals, Inc. announced that the Company granted stock options to three new employees to purchase an aggregate of 57,500 shares of the Company's... https://www.biospace.com/press-releases/crinetics-pharmaceuticals-announces-may-2025-inducement-grants-under-nasdaq-listing-rule-5635c4-may-12-2025 Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)... https://www.biospace.com/verastem-oncology-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-april-4-2024 Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 4, 2024... Apr 4, 2024 - Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock... https://www.biospace.com/dicerna-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-nov-02-2020 Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Nov 02, 2020 - BioSpace Nov 3, 2020 - Dicerna Pharmaceuticals, Inc. announced that the Compensation Committee of the Company's Board of Directors approved inducement grants of stock options to... https://www.barchart.com/story/news/289817/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635c4 Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) WAYNE, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing... https://menafn.com/1109646712/Arcutis-Biotherapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). WESTLAKE VILLAGE, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Arcutis... https://finviz.com/news/343874/korro-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635c4 Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.biospace.com/press-releases/ultragenyx-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-march-19-2025 Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 19, 2025 - BioSpace https://www.biospace.com/arena-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-may-20-2020 Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 20, 2020... May 21, 2020 - Arena Pharmaceuticals, Inc. announced that on May 15, 2020, the Compensation Committee of its Board of Directors granted inducement stock options to purchase... https://www.businesswire.com/news/home/20260313649739/en/Contineum-Therapeutics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4 Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for th... https://menafn.com/1111060303/Intellia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). CAMBRIDGE, Mass., May 01, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics,... intellia therapeutics https://www.biospace.com/deciphera-pharmaceuticals-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-september-15-2023 Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -... Sep 18, 2023 - Deciphera Pharmaceuticals, Inc. announced that in connection with the hiring of Dashyant Dhanak, Ph.D., Executive Vice President and Chief Scientific Officer,... https://www.businesswire.com/news/home/20260330862078/en/Inogen-Inc.-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.biospace.com/syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-may-03-2024 Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - May 03,... Jul 30, 2024 - Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced that on May 1, 2024 the... https://finviz.com/news/212901/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.biospace.com/adicet-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-august-31-2023 Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - August 31, 2023 -... Sep 1, 2023 - Adicet Bio, Inc., a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, announced it granted... https://www.businesswire.com/news/home/20230707807146/en/Kezar-Announces-Inducement-Grant-Under-NASDAQ-Listing-Rule-5635c4 Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Kezar Life Sciences, Inc., (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and o... kezarannouncesinducementgrant https://finviz.com/news/342294/olema-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. oncology reports https://www.biospace.com/press-releases/fulcrum-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-july-11-2025 Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 11, 2025... https://investingnews.com/surrozen-reports-inducement-grants-under-nasdaq-listing-rule-5635/ Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635 | INN Sep 12, 2025 - Surrozen, Inc. ("Surrozen" or the "Company") (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt... reportsinducementgrantsnasdaqlisting https://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/5635.0.40.001Dec%202002?OpenDocument 5635.0.40.001 - Cash Management Trusts, Australia: Data Report, Dec 2002 0 40cash management https://menafn.com/1109758542/Arcutis-Biotherapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). WESTLAKE VILLAGE, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- Arcutis... https://www.biospace.com/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-may-31-2024 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - May 31, 2024... May 31, 2024 - IDEAYA Biosciences, Inc. announced that, on May 30, 2024, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to... https://menafn.com/1111068371/Absci-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635C4 Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4). VANCOUVER, Wash. and NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Absci Corporation... absciannouncesinducementgrant https://www.prnewswire.com/news-releases/fusion-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-301463053.html Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as... https://www.businesswire.com/news/home/20260320045970/en/Evolus-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Evolus, Inc. (NASDAQ: EOLS) a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant during ... reportsinducementgrants https://www.uline.com/Product/ProductDetailRootItem?modelnumber=H-5635 ADA Warning Pads - Surface Mount, 2 x 4' H-5635 - ULINE Uline stocks over 45,000 shipping boxes, packing materials, warehouse supplies, material handling and more. Same day shipping for cardboard boxes, plastic... 2 x 4surface mountadawarningpads https://www.biospace.com/press-releases/evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-to-16-newly-hired-non-executive-employees Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to 16 newly hired... https://www.biospace.com/avidity-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-may-21-2024 Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 21, 2024... Jul 17, 2024 - Avidity Biosciences, Inc. announced that on May 20, 2024, the Human Capital Management Committee of Avidity's Board of Directors granted non-qualified stock... https://www.biospace.com/press-releases/eyepoint-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-march-17-2025 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - March 17,... https://www.biospace.com/press-releases/iovance-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - BioSpace https://stockhouse.com/news/press-releases/2026/03/18/cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 2026-03-18 | Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) |... (2026-03-18 | NDAQ:CYTK) Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) https://www.biospace.com/bellicum-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-april-30-2020 Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 30, 2020 - BioSpace May 1, 2020 - Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers, announced equity inducement grants to one new... https://www.biospace.com/surgalign-holdings-inc-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-nov-04-2021 Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Nov 04,... Nov 5, 2021 - Surgalign Holdings, Inc., a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, announced... https://www.thebusybeeplaycafe.com/ The Busy Bee Play Cafe | Play Cafe | 5635 W 96th St suite 200, Indianapolis, IN, USA The busy bee play cafe is a place where adults and their children can play while enjoying gourmet snacks and coffee. We have an indoor playground, an... the busy bee https://www.f5.com/company/news/press-releases/f5-networks-reports-inducement-grants-under-nasdaq-listing-rule-0 F5 Networks Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | F5 Press Release | F5 https://finviz.com/news/327518/karyopharm-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://finviz.com/news/338446/geron-corporation-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. geron corporation https://www.biospace.com/press-releases/x4-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-june-2-2025 X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 2, 2025... https://www.eclipse.org/lists/technology-pmc/msg03550.html [technology-pmc] [CQ 5635] sisu-inject-plexus Version: 2.3.0 version 2technologypmccq5635 https://finviz.com/news/330037/fate-therapeutics-reports-new-employee-inducement-awards-under-nasdaq-listing-rule-5635c4 Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.biospace.com/press-releases/zenas-biopharma-announces-inducement-grant-under-nasdaq-listing-rule-5635c4-june-20-2025 Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 20, 2025 -... https://finviz.com/news/342336/kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. oncology reports https://www.biospace.com/madrigal-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-april-03-2024 Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 03,... Aug 7, 2024 - Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis, announced that the... https://www.biospace.com/press-releases/pliant-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635c4-september-30-2024 Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - September 30,... https://menafn.com/1109874676/Akebia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Akebia... https://finviz.com/news/342373/syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.biospace.com/neuronetics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-jan-18-2023 Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Jan 18, 2023 - BioSpace Jan 19, 2023 - Neuronetics, Inc. announced the granting of inducement awards to three new non-executive employees. https://www.businesswire.com/news/home/20240607147278/en/Atara-Biotherapeutics-Inc.-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4 Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to dev... https://www.biospace.com/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-july-02-2024 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - July 02, 2024 -... https://www.businesswire.com/news/home/20260403376311/en/Xeris-Announces-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635c4 Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializin... xerisannouncesinducementgrants https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635c4-301095061.html Seelos Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central... https://finviz.com/news/342963/madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635c4 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.biospace.com/press-releases/89bio-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-may-9-2025 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025 - BioSpace https://www.biospace.com/ptc-therapeutics-reports-inducement-grants-under-b-nasdaq-b-listing-rule-5635-c-4-655073 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - BioSpace https://menafn.com/1111060346/ORIC-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 ORIC Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) ORIC Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 01, 2026 (GLOBE NEWSWIRE)... https://www.businesswire.com/news/home/20201231005005/en/Xeris-Pharmaceuticals-Announces-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635c4 Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Xeris Pharmaceuticals, Inc. (NASDAQ: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-t... https://www.businesswire.com/news/home/20240516217789/en/Geron-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase... geronreportsinducementgrants https://www.biospace.com/pliant-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4-june-12-2024 Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 12, 2024... Jul 17, 2024 - Pliant Therapeutics, Inc., announced that on June 10, 2024, it granted stock options to purchase an aggregate of 120,000 shares of common stock upon vesting to... https://www.einpresswire.com/article/645727020/iovance-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Jul 21, 2023 - Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating iovance biotherapeutics https://www.aspiretotalbodysculpt.com/ Aspire Total Body Sculpt | Body Contouring | 5635 NE Alameda St Portland, OR 97213 Aspire Total Body Sculpt provides Non-Invasive Body Sculppting without surgical procedures! With no incisions and no recovery time, it provides a safer, more... total body sculpt https://www.dovernhpt.com/ Dover Physical Therapy, Dover PT | Dover NH 603-343-5635 Dover physical therapy, Dover PT is a state-of-the-art physical therapy clinic in Dover, NH. We can get you better, stronger, faster. physical therapydoverptnh603 https://www.biospace.com/mirati-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-jan-06-2023 Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Jan 06, 2023 -... Jan 9, 2023 - Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, announced that the company granted equity awards to 6 new employees with a grant date of... https://www.businesswire.com/news/home/20260313083043/en/Quantum-Si-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://finviz.com/news/344538/geron-corporation-reports-inducement-grant-under-nasdaq-listing-rule-5635c4 Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. geron corporation https://finviz.com/news/70062/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://finviz.com/news/324826/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.biospace.com/scholar-rock-reports-new-employee-inducement-grants-under-nasdaq-listing-rule-5635-c-4-april-12-2024 Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April... Apr 15, 2024 - Scholar Rock announced that the company granted inducement equity awards covering an aggregate of 45,000 shares of its common stock to two newly hired... https://investingnews.com/aligos-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635/ Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 | INN Sep 9, 2025 - Aligos Therapeutics, Inc. (Nasdaq: ALGS, "Aligos", "Company"), a clinical stage biopharmaceutical company focused on improving patient outcomes through... therapeuticsannouncesinducementgrants https://www.biospace.com/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-dec-02-2020 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Dec 02, 2020 -... Dec 3, 2020 - Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 7 newly-hired... https://finviz.com/news/240603/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.einpresswire.com/article/663197935/dmk-pharmaceuticals-announces-inducement-option-grant-under-nasdaq-listing-rule-5635-c-4 DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4) Oct 20, 2023 - DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial-stage biopharmaceutical company, today announced that the compensation committee of the board of https://www.businesswire.com/news/home/20240506134148/en/Longboard-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurolog... https://www.prnewswire.com/news-releases/karyopharm-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302104524.html Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced...